HealthDay News — Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days before total joint arthroplasty can minimize risks for complications, according to a study presented at ...
13d
MedPage Today on MSNGLP-1 Agents Not Linked to Post-Op Aspiration Pneumonia, More Data SuggestPatients using GLP-1 drugs had no difference in the odds of postoperative aspiration pneumonia versus non-users. Preoperative ...
3d
MedPage Today on MSNStudies Hint at Potential Negative Effects of GLP-1 Drugs in Orthopedic PatientsSAN DIEGO -- Two retrospective studies hinted at potential negative effects of GLP-1 receptor agonists for patients requiring ...
Stopping GLP-1 receptor agonists 14 days prior to total hip or knee arthroplasty may reduce several key risk factors ...
3dOpinion
The Journal News on MSNGLP-1 drugs should require eating disorder screening before prescription | OpinionBy screening people for eating disorders and disordered eating before these medications are prescribed, we can prevent ...
Blockbuster GLP-1 medications are changing patient care, impacting surgery volumes and reshaping the financial landscape of the healthcare industry.
GLP-1 receptor agonists were associated with better graft and patient survival. Clinical trials are needed to confirm these ...
Patients taking GLP-1 drugs also had a 31% lower risk of dying within five ... She is an associate professor of surgery and ...
"To minimize risks of delayed emergence from anesthesia, aspiration, aspiration pneumonitis, and conversion to intubation, ceasing GLP-1 RA 14 days before surgery is optimal," the authors write.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results